NASDAQ : MLYS

Mineralys Therapeutics, Inc. — Earnings Estimates

$27.21 USD

$0.5 (1.87%)

Volume
811.11K
Average Volume
1.5M
Market Capitalization
$2.4B
P/E Ratio
-13.27
Dividend Yield
0.00%
Price Target
$43.00
Year High
$47.65
Year Low
$12.59
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$44.33

Annual earnings financials

MLYS financial data with annual/quarterly toggle

MLYS GAAP EPS - Annual & Quarterly

MLYS Sales Revenue - Annual & Quarterly

MLYS Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

MLYS Estimated and Actual Revenue by Quarter
MLYS Estimated and Actual EPS by Quarter
MLYS Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 - - - - - -
2028-09-30 1 - - - - - -
2028-06-30 1 - - - - - -
2028-03-31 1 - - - - - -
2027-12-31 1 - - - - - -
2027-09-30 1 - - - - - -
MLYS Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 -28.16M -28.16M -28.16M - - -
2028-09-30 1 -32.31M -32.31M -32.31M - - -
2028-06-30 1 -36.45M -36.45M -36.45M - - -
2028-03-31 1 -40.59M -40.59M -40.59M - - -
2027-12-31 1 -45.56M -45.56M -45.56M - - -
2027-09-30 1 -51.08M -51.08M -51.08M - - -
MLYS Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 42M 42M 42M 2 -0.34 -0.34 -0.34
2028-09-30 1 36.5M 36.5M 36.5M 2 -0.39 -0.39 -0.39
2028-06-30 1 31M 31M 31M 2 -0.44 -0.44 -0.44
2028-03-31 1 23.5M 23.5M 23.5M 2 -0.49 -0.49 -0.49
2027-12-31 1 40.83M 40.83M 40.83M 1 -0.55 -0.55 -0.55
2027-09-30 1 23.67M 23.67M 23.67M 1 -0.61667 -0.61667 -0.61667